Skip to main content
. 2022 Jan 19;11:757791. doi: 10.3389/fonc.2021.757791

Figure 10.

Figure 10

(A) The heatmap showed the 3-MRG expression in the prognostic signature based on different risk, clinicopathological characteristics, and survival status in the TCGA cohort. (B) GSEA revealed the top 5 up- and downregulated metabolism-related signaling pathways enriched in low- and high-risk groups. (C–E) The IC50 showed the chemosensitivity of cisplatin, gemcitabine, and paclitaxel in the low- and high-risk groups.